RA
BSX icon

RiverPark Advisors’s Boston Scientific BSX Stock Holding History

RiverPark Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-167
Closed -$15.9K – 155
2025
Q4 		$15.9K Sell
167
-150
-47% -$14.7K ﹤0.01% 160
2025
Q3 		$30.9K Sell
317
-586
-65% -$60.7K 0.01% 136
2025
Q2 		$97K Buy
903
+618
+217% +$62.5K 0.06% 107
2025
Q1 		$28.8K Sell
285
-32
-10% -$3.22K 0.02% 117
2024
Q4 		$28.3K Sell
317
-336
-51% -$29.6K 0.02% 120
2024
Q3 		$54.7K Buy
653
+215
+49% +$16.9K 0.04% 114
2024
Q2 		$33.7K Hold
438
– – 0.03% 122
2024
Q1 		$30K Buy
+438
New +$28.2K 0.02% 122

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RiverPark Advisors's BSX Position: Q1 2026 in Review

RiverPark Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 167 shares — an estimated $15.9K sold.

RiverPark Advisors first reported a position in BSX in Q1 2024 and held it in 8 quarters. The position peaked at $97K in Q2 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • RiverPark Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • RiverPark Advisors sold 167 Boston Scientific shares in Q1 2026, an estimated $15.9K.
  • RiverPark Advisors first reported a position in Boston Scientific in Q1 2024 and held it in 8 quarters.
  • RiverPark Advisors's Boston Scientific position peaked at $97K in Q2 2025.
  • 1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on RiverPark Advisors's 13F filing for Q1 2026, filed 14 May 2026.